advocacy

Do I Really Need to Congratulate That Politician?: Building Working Relationships with Lawmakers Who Make You Cringe

Lisa Hazirjian, Ph.D., Win Together Consulting

Back in November, I published this blog encouraging nonprofit leaders to begin building relationships with elected officials by sending an email congratulating them on their victory. I was surprised and delighted by how much traffic and praise the blog generated. Yet the response I found myself thinking about the most was this question left on LinkedIn by my colleague Veronica LaFemina:

Budgets Matter: Trends & Opportunities to Align Public Budgets with People's Priorities

In this critical moment of recovery with the persistence of barriers to resiliency, public funding for the public good can provide a critical support to protecting families and communities and advancing more equitable outcomes by laying the foundation for a better North Carolina. Essential to making progress in the long-term towards our shared goals is the ability of the state to raise the funds needed and the important role we all can play in making the case for public investments. 

Getting Equity Advocacy Results (GEAR)

It's through continued effort that policy changes to promote equity are implemented and imbedded into practice. Tracking the progress of equity advocacy is important and does not need to be complex or daunting. Getting Equity Advocacy Results (GEAR) from PolicyLink is a suite of benchmarks, methods, and tools for advocates, organizers, and their allies to track the results of their equity campaigns to:

Communications in a Post-COVID World: How to Advocate Strategically for Your Nonprofit’s Mission

When COVID-19 hit, our world changed. Organizations had to decide how to move forward while dealing with unanswered questions about what this would mean for your team, for your stakeholders, and for your partners. While nonprofits’ missions are more important than ever, the public, media, and funders are focused on work and messages directly related to COVID-19.